In addition, there is the evidence that overexpression of p65/NF-κB suppresses the TET1 expression in triple-negative breast cancer, skin cutaneous melanoma (SKCM), thyroid carcinoma (THCA), and lung adenocarcinoma (LUAD) cell lines [157]. This evidence concerns the gene NFKB1 and triple-negative breast carcinoma.